Evotec’s ScreenPep™ : the new benchmark in high-throughput proteomics

Name: Evotec’s ScreenPep™ : the new benchmark in high-throughput proteomics
Brand: Evotec

Credit: Evotec

Evotec's proteomics platforms offer a comprehensive and cutting-edge suite of technologies designed to advance the understanding of protein function and dynamics, facilitating drug discovery and development. These platforms leverage advanced mass spectrometry, state-of-the-art instrumentation, and automated workflows to deliver high-throughput and high-precision proteomics analyses.

Our ScreenPep™ platform sets a new benchmark in high-throughput proteomics by enabling the analysis of thousands of samples at unparalleled speed and depth. Capable of detecting over 10,000 proteins from cells or tissues. Combining high-end mass spectrometry with automated sample preparation to achieve exceptional coverage and precision.

The platform's fully automated workflow encompasses cell culture, sample preparation, LC-MS/MS data acquisition, and data processing, ensuring consistent and reliable results. Additionally, ScreenPep™ can quantify various post-translational modifications, such as phosphorylation, ubiquitination, acetylation, and methylation, making it a versatile tool for detailed proteomic studies.

Watch our video

Learn more about our PanOmics approach to drug discovery

About Evotec

Evotec are a R&D biotech that offers accelerating, high value pipeline co-creation partnerships and comprehensive CRO/CDMO services – always striving for highest quality, capital efficient execution of R&D programs from disease understanding towards IND, Phase 1, and beyond. Our expertise spans across therapeutic/disease areas and most modalities, especially small molecules and biotherapeutics. We take pride in acting as "drug hunters" in deep collaboration with our partners to advance science. At the core of our operations are our industrialized, AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies. These platforms are instrumental in enhancing disease understanding and ensuring human relevance in our research. By integrating AI and continuous manufacturing technology, we facilitate better access to high-quality biotherapeutics, revolutionizing the way treatments are developed and produced.

Interested in seeing more content from Evotec?

Discover all their latest news, webinars, products and more by clicking the link below.

Chosen for You